Acarix AB (publ) (“Acarix”) will present its CADScor®System for non-invasive, non-radiation acoustic rule-out of Coronary Artery Disease (CAD) at the German Heart Days in Berlin, October 12-14. The device has so far been launched in the Nordics and Germany and created a great deal of interest. Furthermore, a new analysis of historic German data to be presented at the conference will point to clear opportunities for improving efficiencies by introducing innovations such as the CADScor®System in the current testing regime for CAD.

Press Release (PDF)